solid pancreatic lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who need histopathological diagnosis for solid pancreatic lesions by EUS-FNB. (2) Patients who provided written informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients in European Cooperative Oncology Group performance status 4. (2) Patients with severe adverse events in other organs except those involving the original disease (American Society of Anesthesiologists classification greater than 3). (3) Patients contraindicated for cessation of anticoagulant therapy. (4) Pregnant patients or those suspected of being pregnant. (5) Solid pancreatic lesions with definite diagnosis by another biopsy. (6) Solid pancreatic lesions demonstrating difficulty in visualization on EUS. (7) Patients who judged as inappropriate by attendant doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The accuracy of histological diagnosis by the number of to-and-fro movements. | — |
Secondary
| Measure | Time frame |
|---|---|
| The total area of the specimen by the number of to-and-fro movements. | — |
Countries
Japan
Contacts
Nagoya University Graduate School of Medicine Department of gastroenterology